The purpose of this study was to examine the effect of ACGCC on enduring time ofmice.184 healthy mice (ICR) at the age of 5-6 weeks, weight of 26±3.68g, and 23.72±10mins of pre-test enduring time were subjects. Subjects were randomly assigned into four groups [no ACGCC no exercise group (C1), no ACGCC exercise group (C2), ACGCC no exercise group (M1), and ACGCC exercise group (M2)] with sex and pre-test enduring time. The medicinal groups were asked to oral injecting 100mg ACGCC six days every week. After second and fourth weeks, subjects were asked to exercise to exhaust on a treadmill.
The result from this study shows as follows:
1.The enduring time was higher in post-test than in pre-test after second and fourth weeks in M2 groups in male and female mice(p＜0.01).
2.The enduring time was lower in post-test than in pre-test after second and fourth week sin C1 and M1 groups in male and female mice(p＜0.05, p＜0.01).
3.The enduring time was no significant difference in pre-test and post-test after second and fourth weeks in C2 groups in male and female mice.
4.The enduring time was higher in post-test in M2 groups than in C1,C2,and M1 groups after second and fourth weeks in male mice(p＜0.05).
5.The enduring time was higher in post-test in M2 groups than in C1, C2, and M1 groups after second week in female mice(p＜0.05).
6. The enduring time was higher in post-test in C2 and M2 groups than in C1 and M1groups after fourth week in female mice (p＜0.05).
This result indicates that the increased enduring time is associated with ACGCC and training. Enduring time can be stimulated by an additive synergistic effect between ACGCC and training.
